The Smart Insulin Pens Industry Is Creating Next Generation Products Which Boost The Market

EINPRESSWIRE Press Release
Smart Insulin Pens Market Report 2021: COVID-19 Growth And Change To 2030

Smart Insulin Pens Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Smart Insulin Pens Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, March 24, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The next generation smart insulin pens go far beyond memory storage. They help in calculating personalized doses, track glucose continuously and connect with apps of smartphones to visualize the data. In 2019, Novo Nordisk and Abbott partnered to integrate insulin dose data into digital health tools, which aims at connecting key technologies such as continuous glucose monitoring and insulin pens, thus simplifying diabetes management. The NovoPen 6 and the NovoPen Echo Plus pens will be able to connect to the Dexcom G6 CGM and the Diasend diabetes management platform (Glooko). In 2019, Companion Medical announced that the Bluetooth-enabled InPen which takes away the guesswork from dosing of insulin with an in-app bolus calculator that uses precise carbohydrate ratios and correction factors and calculates the personalized insulin doses. This enhances the ease of usage of smart insulin pens which is expected to boost the market.

Other smart insulin pen market trends include partnerships between companies. In February 2020, Senseonics a US-based medical technology company which primarily focuses on the design, development and commercialization of glucose monitoring products announced partnership with Companion Medical. The partnership will benefit both the companies by integrating Eversense® CGM System with the InPen™ smart system for accurate insulin delivery. Companion Medical is a US-based company which aims at achieving desirable diabetes outcomes and manufactured InPen™ which is the US first FDA approved insulin pen.

Major players in the global smart insulin pens industry are Companion Medical, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu Medical Device Co. Ltd., and Bigfoot Biomedical.

Read More On The Global Smart Insulin Pens Market Report:
https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-market-global-report-2020-30-covid-19-growth-and-change

The smart insulin pens market covered in this report is segmented by type into first generation pens, second generation pens (Bluetooth enabled, USB connected); by end user into hospitals & clinics, ambulatory surgical centers, home care settings; by usability into prefilled, reusable; by application into type 1 diabetes, type 2 diabetes.

The global smart insulin pens market size is expected grow from $82 million in 2020 to $86 million in 2021 at a compound annual growth rate (CAGR) of 4.9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global smart insulin pens market is expected to reach $114 million in 2025 at a CAGR of 7%.

Smart Insulin Pens Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides smart insulin pens market overview, forecast smart insulin pens market size and growth for the whole market, smart insulin pens market segments, and geographies, smart insulin pens market trends, smart insulin pens market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Smart Insulin Pens Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3090&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Insulin Pens, Syringes, Pumps And Injectors Market – By Devices (Pens, Injectors And Pumps, Syringes), By End-User (Homecare, Hospitals And Others), By Expenditure (Private, Public Healthcare), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Diabetes Care Devices Market – By Type (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors), By Applications, And By Region, Opportunities And Strategies – Global Forecast To 2022
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Implantable Infusion Pumps Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report-2020-30-covid-19-growth-and-change

Insulin Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn